Rapid achievement of MR(4.5) after switching from imatinib (IM) to nilotinib (NIL) in patients (Pts) with chronic myeloid leukemia in chronic phase (CML-CP): Preliminary results from ENESTgoal Meeting Abstract


Authors: Ritchie, E. K.; Catchatourian, R.; Klisovic, R. B.; Deininger, M. W.; Erba, H. P.; Radich, J. P.; Savona, M. R.; Warsi, G.; Paley, C. S.; Dautaj, I.; Lin, F. P.; Mauro, M. J.
Abstract Title: Rapid achievement of MR(4.5) after switching from imatinib (IM) to nilotinib (NIL) in patients (Pts) with chronic myeloid leukemia in chronic phase (CML-CP): Preliminary results from ENESTgoal
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368021800307
PROVIDER: wos
DOI: 10.1182/blood.V126.23.4050.4050
Notes: Meeting Abstract: 4050 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    272 Mauro